COMBINATION OF ITRIGLUMIDE AND PPI FOR THE TREATMENT OF GASTROINTESTINAL AND ASSOCIATED DISEASES

摘要

The invention relates to the combination of the chole-cystokinin-2 (CCK-2) receptor antagonist Itriglumide and proton pump inhibitors (PPIs) for the treatment of patients suffering from gastrointestinal and related disorders.